Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Leukocyte Biology

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1189/jlb.1105674PMID 16707558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multilevel Regulation of IL‐6R by IL‐6–sIL‐6R Fusion Protein According to the Primitiveness of Peripheral Blood‐Derived CD133+ Cells

  2006cited by this paper
• Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.

  2006cited by this paper
• Designer cytokines for human haematopoietic progenitor cell expansion: impact for tissue regeneration.

  2006cited by this paper
• A form of circulating interleukin‐6 receptor component soluble gp130 as a potential interleukin‐6 inhibitor in inflammatory bowel disease

  2006cited by this paper
• Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis.

  2006cited by this paper
• IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer

  2005cited by this paper
• Design of effective immunotherapy for human autoimmunity

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

  2005cited by this paper
• Designing cytokine variants by phage-display.

  2005cited by this paper
• Endogenous Interleukin-6 Plays a Crucial Protective Role in Streptococcal Toxic Shock Syndrome via Suppression of Tumor Necrosis Factor Alpha Production

  2005cited by this paper
• IL-6 Increases Primed Cell Expansion and Survival

  2005cited by this paper
• Endogenous interleukin-6, but not tumor necrosis factor alpha, contributes to the development of toll-like receptor 4/myeloid differentiation factor 88-mediated acute arthritis in mice.

  2005cited by this paper
• Local delivery of soluble interleukin-6 receptors to improve the outcome of alpha-toxin producing Staphylococcus aureus infection in mice.

  2005cited by this paper
• The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody

  2005cited by this paper
• IL-6 transsignaling: the in vivo consequences.

  2005cited by this paper
• IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

  2005influential reference
• No inhibition of IL-27 signaling by soluble gp130.

  2005influential reference
• Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-61

  2005influential reference
• Pathological role of IL-6 in the experimental allergic bronchial asthma in mice

  2005cited by this paper
• Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling

  2005cited by this paper
• Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody

  2004cited by this paper
• Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress.

  2004cited by this paper
• The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis.

  2004cited by this paper
• Differential Regulation of Neutrophil-Activating Chemokines by IL-6 and Its Soluble Receptor Isoforms1

  2004cited by this paper
• The interface between innate and adaptive immunity

  2004cited by this paper
• A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

  2004cited by this paper
• Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

  2004influential reference
• Dose-dependent neurochemical and functional protection afforded by encapsulated CNTF-producing cells.

  2004cited by this paper
• IL-6 trans-signaling: the heat is on.

  2004cited by this paper
• TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

  2004cited by this paper
• Novel immunosuppressive properties of interleukin‐6 in dendritic cells: inhibition of NF‐κB binding activity and CCR7 expression

  2004cited by this paper
• The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10 1

  2004cited by this paper
• Inhibition of T Cell Apoptosis in the Aqueous Humor of Patients with Uveitis by IL-6/Soluble IL-6 Receptor trans-Signaling

  2004cited by this paper
• WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27

  2004influential reference
• Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent

  2004cited by this paper
• Increased and Long-Term Generation of Dendritic Cells with Reduced Function from IL-6-Deficient Bone Marrow1

  2004cited by this paper
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004cited by this paper
• Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor.

  2004cited by this paper
• The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

  2003cited by this paper
• Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation

  2003cited by this paper
• Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

  2003cited by this paper
• Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)*

  2003cited by this paper
• IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation.

  2003cited by this paper
• Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice

  2003cited by this paper
• Transcriptional profiling identifies Id2 function in dendritic cell development

  2003cited by this paper
• Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines.

  2003cited by this paper
• Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells

  2003cited by this paper
• Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited

  2003cited by this paper
• Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130

  2003cited by this paper
• The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.

  2002cited by this paper
• The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex.

  2002cited by this paper
• The effect of gp130 stimulation on glutamate-induced excitotoxicity in primary hippocampal neurons.

  2002cited by this paper
• The Interface Between Innate and Acquired Immunity

  2002cited by this paper
• The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.

  2002cited by this paper
• Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.

  2002cited by this paper
• Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

  2002cited by this paper
• Functionally active fusion protein of the novel composite cytokine CLC/soluble CNTF receptor.

  2002cited by this paper
• GP130 stimulation and the maintenance of stem cells.

  2002cited by this paper
• Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex

  2001cited by this paper
• Coordination of interleukin-6 biology by membrane bound and soluble receptors.

  2001cited by this paper
• Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells.

  2001cited by this paper
• The soluble interleukin 6 receptor: mechanisms of production and implications in disease

  2001cited by this paper
• Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis

  2001cited by this paper
• Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins.

  2001cited by this paper
• Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation.

  2001cited by this paper
• Tissue-Specific Autoregulation of thestat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells

  2001cited by this paper
• Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

  2001cited by this paper
• The importance of shedding of membrane proteins for cytokine biology.

  2000cited by this paper
• IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis1

  2000cited by this paper
• Astrocytic Alterations in Interleukin-6/Soluble Interleukin-6 Receptor α Double-Transgenic Mice

  2000cited by this paper
• Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis.

  2000cited by this paper
• IL-6 Receptor Independent Stimulation of Human gp130 by Viral IL-61

  2000cited by this paper
• Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis.

  2000cited by this paper
• Endogenous and Exogenous IL-6 Inhibit Aeroallergen-Induced Th2 Inflammation1

  2000cited by this paper
• Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice

  2000cited by this paper
• IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

  2000cited by this paper
• Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells

  2000cited by this paper
• Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.

  2000cited by this paper
• Activation-Induced Inhibition of Interleukin 6–Mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling

  2000cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• New perspectives on the design of cytokines and growth factors.

  2000cited by this paper
• Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells.

  2000cited by this paper
• IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage.

  2000cited by this paper
• Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone.

  1999cited by this paper
• Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis.

  1999cited by this paper
• Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors

  1999cited by this paper
• Receptor Recognition Sites of Cytokines Are Organized as Exchangeable Modules

  1999cited by this paper
• Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.

  1999cited by this paper
• The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses.

  1999cited by this paper
• Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

  1999cited by this paper
• A fusion protein of interleukin‐11 and soluble interleukin‐11 receptor acts as a superagonist on cells expressing gp130

  1999cited by this paper
• Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice.

  1999cited by this paper
• IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

  1998cited by this paper
• A New Type of Cytokine Receptor Antagonist Directly Targeting gp130*

  1998cited by this paper
• A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis.

  1998cited by this paper
• Sympathetic neurons can produce and respond to interleukin 6.

  1998cited by this paper
• Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis.

  1998cited by this paper
• IL‐6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice

  1998cited by this paper
• Interleukin 6 Is Required for the Development of Collagen-induced Arthritis

  1998cited by this paper

• Inflammatory milieu and role of epigenetic modifications in high-grade serous ovarian cancer.

  2026cites this paper
• Interleukin-6: A Central Biomarker in Adult and Pediatric Cancer and Infectious Disease

  2026cites this paper
• CD4+ T‐Cell‐Intrinsic IL‐6 Is Critical for Th17 Differentiation and Dampened Responsiveness to CD8+ T Cell‐Mediated Suppression

  2026cites this paper
• The Mechanosensitive PIEZO1 Channel Contributes to the Reaction of RAW264.7 Macrophages to Mechanical Strain

  2025cites this paper
• OXIDATIVE STRESS, ANTIOXIDANT ACTIVITY AND CYTOKINE PROFILE IN PATIENTS WITH ABDOMINAL SEPSIS

  2025cites this paper
• Moving Towards the Delivery of Outpatient T-Cell Engaging Therapy for the Management of Multiple Myeloma.

  2025cites this paper
• Neuroprotective properties of ciliary neurotrophic factor in the retina for the treatment of macular telangiectasia type 2.

  2025cites this paper
• A review on the role of IL-6 in the onset and progression of nasopharyngeal carcinoma

  2025cites this paper
• Context dependent role of miR-486 promoting neuroregeneration of primary sensory neurons downstream of interleukin-6 signal transducer

  2025cites this paper
• Advances in the clinical application of bispecific antibodies in cancer therapy

  2025cites this paper
• Potential mechanism of Qigebikang tablets in the treatment of allergic rhinitis: Network pharmacology and molecular docking

  2025cites this paper
• Targeting the major pro-inflammatory interleukin-6-type cytokine receptor gp130 by antagonistic single domain antibodies

  2025cites this paper
• IL-6 trans-signaling: an overlooked driver of retinal neovascularization?

  2025cites this paper
• RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch

  2025cites this paper
• Blockade of Interleukin-6 Trans-signaling in the Presence of Certain Gut Microbiota Induces Mature-onset Obesity in Mice

  2025cites this paper
• Astaxanthin targets IL-6 and alleviates the LPS-induced adverse inflammatory response of macrophages.

  2024cites this paper
• Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes.

  2024cites this paper
• MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer

  2024cites this paper
• Serum Level Alteration of IL-6, IL-1β, and IFN-γ in Groups of Healthy Adults with Oxidative DNA Damage in Najaf Governorate

  2024cites this paper
• Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors

  2024cites this paper
• Evolution of a bispecific G-quadruplex-forming circular aptamer to block IL-6/sIL-6R interaction for inflammation inhibition

  2024cites this paper
• Causal associations between circulating inflammatory cytokines and blinding eye diseases: a bidirectional Mendelian randomization analysis

  2024cites this paper
• Validation of an Analytical Procedure for Evaluating the Biological Activity of a Medicinal Product Based on Tocilizumab and Determination of Acceptance Criteria for Test Results

  2024cites this paper
• The role of chemokines and interleukins in acute lymphoblastic leukemia: a systematic review.

  2024cites this paper
• The Inflammatory Cytokines in Rheumatoid Arthritis and Their effect in the Progression and Pathogenesis of the Disease

  2024influential citation
• No Effects of Omega-3 Supplementation on Kynurenine Pathway, Inflammation, Depressive Symptoms, and Stress Response in Males: A Placebo-Controlled Trial

  2024cites this paper
• Alterations of receptors and insulin-like growth factor binding proteins in senescent cells.

  2024cites this paper
• Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody

  2023cites this paper
• Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages

  2023cites this paper
• Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study

  2023cites this paper
• Muscle-to-organ cross-talk mediated by interleukin 6 during exercise: a review

  2023cites this paper
• A CLINICO PATHOLOGICAL STUDY OF PRE-OPERATIVE SERUM INTERLEUKIN-6 AND C-REACTIVE PROTEIN LEVELS IN BREAST CANCER PATIENTS

  2023cites this paper
• Extracellular targeted protein degradation: an emerging modality for drug discovery

  2023cites this paper
• The influence of SARS‐CoV‐2 infection on expression of drug‐metabolizing enzymes and transporters in a hACE2 murine model

  2023cites this paper
• Functional role of skeletal muscle-derived interleukin-6 and its effects on lipid metabolism

  2023cites this paper
• The occurrence and development of radiation-induced lung injury after interstitial brachytherapy and stereotactic radiotherapy in SD rats

  2023cites this paper
• Inhibition of Interleukin-6 dependent metalloproteinases-9/2 expression in cancer cells by diet polyphenols.

  2023cites this paper
• The Neuroimmune System and the Cerebellum

  2023cites this paper
• In vitro effects of undifferentiated callus extracts from Plantago major L, Rhodiola rosea L and Silybum marianum L in normal and malignant human skin cells

  2023cites this paper
• Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives

  2023cites this paper
• Modulators of radiation-induced cardiopulmonary toxicities for non-small cell lung cancer: Integrated cytokines, single nucleotide variants, and HBP systems imaging

  2022cites this paper
• Obesity and Thyroid Cancer Risk: An Update

  2022cites this paper
• HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer

  2022cites this paper
• IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden

  2022cites this paper
• Resveratrol ameliorates nutritional steatohepatitis through the mmu-miR-599/PXR pathway

  2022influential citation
• Serious adverse events and coping strategies of CAR-T cells in the treatment of malignant tumors

  2022cites this paper
• The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities

  2022cites this paper
• IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden

  2022cites this paper
• Effects of the Interleukin-6 Receptor Blocker Sarilumab on Metabolic Activity and Differentiation Capacity of Primary Human Osteoblasts

  2022cites this paper
• Single‐cell transcriptomics reveals a senescence‐associated IL‐6/CCR6 axis driving radiodermatitis

  2022cites this paper
• Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions

  2022cites this paper
• IL-6 promotes low concentration of RANKL-induced osteoclastic differentiation by mouse BMMs through trans-signaling pathway

  2022cites this paper
• IL-6: The Link Between Inflammation, Immunity and Breast Cancer

  2022cites this paper
• Proinflammatory Cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-α) Single Nucleotide Polymorphisms in Rheumatoid Arthritis—A Literature Review

  2022cites this paper
• Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

  2022cites this paper
• Mechanisms of immune effector cell‐associated neurotoxicity syndrome after CAR‐T treatment

  2022cites this paper
• Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database

  2022cites this paper
• Selective Inhibition of IL-6 Trans-Signaling Has No Beneficial Effect on the Posttraumatic Cytokine Release after Multiple Trauma in Mice

  2021cites this paper
• Провоспалительные цитокины при хронической сердечной недостаточности: состояние проблемы

  2021cites this paper
• Uncovering key targets of success for immunotherapy in pancreatic cancer

  2021cites this paper
• Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background

  2021cites this paper
• Mechanism, Prevention, and Treatment of Radiation-Induced Salivary Gland Injury Related to Oxidative Stress

  2021cites this paper
• Posttranslational modifications by ADAM10 shape myeloid antigen-presenting cell homeostasis in the splenic marginal zone

  2021cites this paper
• Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis

  2021cites this paper
• IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives

  2021cites this paper
• Chlamydia trachomatis. Co-factor or factor in cancer of the cervix?

  2021cites this paper
• Low expression of IL6R predicts poor prognosis for lung adenocarcinoma

  2021cites this paper
• Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis

  2021cites this paper
• Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm

  2021cites this paper
• Hyper-Interleukin-6 Protects Against Renal Ischemic-Reperfusion Injury—A Mouse Model

  2021cites this paper
• Role of IL-6 in the regulation of neuronal development, survival and function.

  2021cites this paper
• TURMERIC EXTRACT POTENTIAL INHIBIT INFLAMMATORY MARKER IN LPS-STIMULATED MARCOPHAGE CELLS

  2021cites this paper
• The Soluble (Pro)Renin Receptor in Health and Diseases: Foe or Friend?

  2021cites this paper
• Characterisation of the Mouse Cerebellar Proteome in the GFAP-IL6 Model of Chronic Neuroinflammation

  2021cites this paper
• Dysbacteriosis induces abnormal neurogenesis via LPS in a pathway requiring NF-κB/IL-6.

  2021cites this paper
• Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets

  2021cites this paper
• Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis

  2021cites this paper
• The Value of Detecting Pathological Changes During Clot Formation in Early Disease Treatment-Naïve Breast Cancer Patients

  2021cites this paper
• Increased IL‐6 and Potential IL‐6 trans‐signalling in the airways after an allergen challenge

  2021cites this paper
• Cytokine Release Syndrome Associated with T-Cell-Based Therapies for Hematological Malignancies: Pathophysiology, Clinical Presentation, and Treatment

  2021cites this paper
• Ischemia augments alloimmune injury through IL-6-driven CD4(+) Ischemia augments alloimmune injury through IL-6-driven CD4(+) alloreactivity alloreactivity Let us know how access to this document benefits you.

  2021cites this paper
• Triggers of Cardiovascular Diseases in Rheumatoid Arthritis.

  2021cites this paper
• Sex differences in neuro(auto)immunity and chronic sciatic nerve pain

  2020influential citation
• Level of selected pro-inflammatory markers in middle-aged women with Hashimoto’s disease

  2020cites this paper
• Interleukin‐6 pathobiology in equine placental infection

  2020cites this paper
• Role of IL-6 and STAT3 signaling in dihydropyridine-induced gingival overgrowth fibroblasts.

  2020cites this paper
• Recurrence of type 1 diabetes after beta-cell replacement

  2020cites this paper
• Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications

  2020cites this paper
• Effector Mechanisms in Autoimmunity

  2020cites this paper
• Peripheral sgp130-mediated trans-signaling blockade induces obesity and insulin resistance in mice via PPARα suppression

  2020cites this paper
• Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis

  2020cites this paper
• Effect of Acute and Prolonged Inflammation on the Gene Expression of Proinflammatory Cytokines and Their Receptors in the Anterior Pituitary Gland of Ewes

  2020cites this paper
• Immunomodulation of IL6 transsignaling in polytrauma: organ specific effects of in vivo simulation in a murine multiple trauma model

  2020cites this paper
• Pro-Inflammatory Cytokines as Potential Early Biomarkers and Therapeutic Targets to Combat Ischemic Stroke

  2020cites this paper
• Integrated network pharmacology and molecular docking strategy to explore the mechanism of medicinal and edible Astragali Radix-Atractylodis Macrocephalae Rhizoma acting on pneumonia via immunomodulation.

  2020cites this paper
• Lactoferrin in the Prevention and Treatment of Intestinal Inflammatory Pathologies Associated with Colorectal Cancer Development

  2020cites this paper
• Multi-dimensional COVID-19 short- and long-term outcome prediction algorithm

  2020cites this paper
• Evaluation of biomarkers in chronic inflammatory diseases

  2020cites this paper
• Integrated network analysis of symptom clusters across disease conditions

  2020cites this paper
• Molecular basis of diseases of the gastrointestinal tract

  2020cites this paper